Literature DB >> 5041701

A prospective study of the value of monitoring heparin treatment with the activated partial thromboplastin time.

D Basu, A Gallus, J Hirsh, J Cade.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 5041701     DOI: 10.1056/NEJM197208172870703

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  82 in total

Review 1.  Anticoagulation in patients with thromboembolic disease.

Authors:  R C Tait
Journal:  Thorax       Date:  2001-09       Impact factor: 9.139

2.  Description and Evaluation of the Implementation of a Weight-Based, Nurse-Driven Heparin Nomogram in a Tertiary Academic Medical Center.

Authors:  James W Schurr; Craig A Stevens; Anne Bane; Carol Luppi; Sarah E Culbreth; Amy Leigh Miller; Jean M Connors; Katelyn W Sylvester
Journal:  Clin Appl Thromb Hemost       Date:  2017-08-04       Impact factor: 2.389

3.  Deep Vein Thrombosis.

Authors: 
Journal:  Curr Treat Options Cardiovasc Med       Date:  1999-06

4.  Comparison of two different ecarin clotting time methods.

Authors:  Tivadar Fenyvesi; Job Harenberg; Christel Weiss; Ingrid Jörg
Journal:  J Thromb Thrombolysis       Date:  2005-08       Impact factor: 2.300

Review 5.  Parenteral anticoagulants: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  David A Garcia; Trevor P Baglin; Jeffrey I Weitz; Meyer Michel Samama
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

6.  Spontaneous haemarthrosis following thrombolytic therapy for myocardial infarction.

Authors:  K G Oldroyd; R S Hornung; A M Jones; N P Andrews; P T Dawes; P H Carson
Journal:  Postgrad Med J       Date:  1990-05       Impact factor: 2.401

Review 7.  Anticoagulants in older patients. A safety perspective.

Authors:  R J Beyth; C S Landefeld
Journal:  Drugs Aging       Date:  1995-01       Impact factor: 3.923

8.  Anticoagulant therapy.

Authors:  J M Teitel
Journal:  Can Fam Physician       Date:  1984-09       Impact factor: 3.275

9.  Comparison of Time to Therapeutic aPTT in Patients Who Received Continuous Unfractionated Heparin After Implementation of Pharmacy-wide Intervention Alerts.

Authors:  Duaa Alsulaiman; Katelyn Sylvester; Craig Stevens; Danielle Carter
Journal:  Hosp Pharm       Date:  2016-09

10.  Venous thromboembolism in the elderly. A community-based perspective.

Authors:  Frederick A Spencer; Joel M Gore; Darleen Lessard; Cathy Emery; Luigi Pacifico; George Reed; Jerry H Gurwitz; Robert J Goldberg
Journal:  Thromb Haemost       Date:  2008-11       Impact factor: 5.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.